Cargando…

The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India

Background. The efficacy, safety, and cost benefit of olanzapine (OLN) when compared to aprepitant (APR) in the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) were evaluated. Methods. A prospective pilot study was done in chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babu, Govind, Saldanha, Smitha Carol, Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah, Jacob, Linu Abraham, Mallekavu, Suresh Babu, Dasappa, Loknatha, Kiran, Pretesh Rohan, Sreevatsa, Aparna, Appachu, Sandhya, Unnikrishnan, Vineetha, Arroju, Venugopal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748067/ https://www.ncbi.nlm.nih.gov/pubmed/26925265 http://dx.doi.org/10.1155/2016/3439707

Ejemplares similares

Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience
por: Babu Kanakasetty, Govind, et al.
Publicado: (2016)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
por: Jacob, Linu A., et al.
Publicado: (2015)

Prognostic significance of bone only metastasis compared to visceral metastasis in patients with carcinoma cervix treated with platinum-based chemotherapy
por: Mallekavu, Suresh Babu, et al.
Publicado: (2017)

Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India
por: Kuntegowdanahalli, Lakshmaiah Chinnagiriyappa, et al.
Publicado: (2016)

Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India
por: Haleshappa, Rudresha Antapura, et al.
Publicado: (2017)

Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness
por: Jacob, Linu A., et al.
Publicado: (2015)

Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India
por: Lokesh, K. N., et al.
Publicado: (2017)

Pharmacoeconomic benefit of cisplatin and etoposide chemoregimen for metastatic non small cell lung cancer: An Indian study
por: Kamath, Mangesh P, et al.
Publicado: (2016)

T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India
por: Babu MC, Suresh, et al.
Publicado: (2018)

Correlation of BMI with breast cancer subtype and tumour size
por: Govind Babu, K, et al.
Publicado: (2018)

Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India
por: Babu, Govind K, et al.
Publicado: (2017)

Locally advanced oral cavity squamous cell carcinoma: Barriers related to effective treatment
por: Lakshmaiah, K. C., et al.
Publicado: (2015)

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children
por: Lee, So Rae, et al.
Publicado: (2020)

Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India
por: Lakshmaiah, K.C., et al.
Publicado: (2017)

Cost‐effectiveness of aprepitant in Japanese patients treated with cisplatin‐containing highly emetogenic chemotherapy
por: Tsukiyama, Ikuto, et al.
Publicado: (2018)

Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India
por: Rudresha, A. H., et al.
Publicado: (2017)

Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India
por: Rudresha, AH, et al.
Publicado: (2017)

Primary Diffuse large B-Cell lymphoma of testis: A single centre experience and review of literature
por: Lokesh, Kadabur Nagendrapp, et al.
Publicado: (2014)

Is Colorectal Cancer in Young (<40 Years) Different from those in the Elderly (>40 Years): Experience from a Regional Care Center
por: Haleshappa, Rudresha A, et al.
Publicado: (2017)

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
por: Yoshida, Naohisa, et al.
Publicado: (2019)

Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience
por: Lokesh, K. N., et al.
Publicado: (2018)

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
por: Kang, Jin Hyoung, et al.
Publicado: (2020)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
por: Jin, Yilan, et al.
Publicado: (2021)

Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
por: Babu, K. Govind, et al.
Publicado: (2018)

Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
por: Babu, K. Govind, et al.
Publicado: (2019)

The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy
por: Eghbali, Aziz, et al.
Publicado: (2023)

Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India
por: Suresh, Babu, et al.
Publicado: (2019)

Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
por: Hingmire, Sachin, et al.
Publicado: (2015)

Primary central nervous system lymphoma in immunocompetent patients: A regional cancer center experience
por: Rudresha, A. H., et al.
Publicado: (2017)

Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy
por: Navari, Rudolph M, et al.
Publicado: (2019)

Single‐dose NEPA versus an aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
por: Zelek, Laurent, et al.
Publicado: (2023)

Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cell-free tumor DNA using next generation sequencing in squamous cell carcinoma lung
por: Govind, Kanakasetty Babu, et al.
Publicado: (2019)

Rapidly Progressing Plasma Cell Leukemia with Underlying Plasmablastic Morphology: A Rare Case Report of a 25-Year Old Male
por: Saldanha, Smitha, et al.
Publicado: (2022)

Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy
por: Toda, Haruka, et al.
Publicado: (2017)

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
por: Zelek, Laurent, et al.
Publicado: (2021)

Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy
por: Abe, Masakazu, et al.
Publicado: (2015)

Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
por: Miya, Toshimichi, et al.
Publicado: (2016)

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy
por: Tanioka, M, et al.
Publicado: (2013)

Human Immunodeficiency Virus – Associated Lymphomas: A Neglected Domain
por: Sirsath, Nagesh Tatero, et al.
Publicado: (2013)

Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
por: Kondo, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qov6n25ljmlgev0qgjgq5ngcqq